{"url_path":"/sec/jsprw/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-060029-index.html","accession_number":"0001213900-26-060029","cik":"0001788028","ticker":"JSPR","issuer_name":"Jasper Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-060029-index.html","primary_entity_key":"0001788028","primary_entity_name":"Jasper Therapeutics, Inc."},"word_count":75,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n** **\n\n**(d) Exhibits.**\n\n** **\n\n**Number**\n \n**Description**\n\n104\n \nCover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).\n\n \n\n1 \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange\nAct of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**JASPER THERAPEUTICS, INC.**\n\n \n \n \n\nDate: May 21, 2026\nBy:\n/s/ Jeet Mahal\n\n \n \nName: Jeet Mahal\n\n \n \nTitle: Chief Executive Officer\n\n \n\n2"}